Karolinska Development Ab (publ) And Biochromix Ab
STOCKHOLM, January 14 - Karolinska Development AB (publ), and BioChromix AB announced today the
formation of BioChromix Pharma AB, a new company working to develop a novel
Alzheimer treatment with its unique knowledge of molecular chemistry.
